Reversible and Irreversible Inhibitors of the Cell Cycle-Associated Kinases CDK2 and Nek2 as Prospective Antitumour Agents
| Dates: | 27 November 2013 |
|---|
| Times: | 13:00 - 14:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Manchester Pharmacy School |
|---|
| Who is it for: | Alumni, Current University students, University staff |
|---|
| Speaker: | Professor Roger Griffin |
|---|
|
Host: Manchester Pharmacy School
About the event:
Biography:
Roger Griffin is Professor of Medicinal Chemistry and Co-director of Drug Development at Newcastle University's Northern Institute for Cancer Research (NICR). A graduate in Pharmacy at the University of Portsmouth in 1981, he completed a PhD in Medicinal Chemistry at Aston University, before taking up a lectureship in the Department of Pharmaceutical Sciences in 1985. He moved to Newcastle in 1990, and was appointed to his current post in 2001. The main focus of Roger Griffin's research is anticancer medicinal chemistry
Speaker
Professor Roger Griffin
Organisation: Northern Institute for Cancer Research School of Chemistry, Newcastle University
Travel and Contact Information
Find event
Lecture theatre 6
Stopford Building
Manchester
